| 000 | 01755 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518000933.0 | ||
| 264 | 0 | _c20190306 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0204567 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaiti, Arpan K | |
| 245 | 0 | 0 |
_aColonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFNγ and TNFα induced during Citrobacter rodentium infection. _h[electronic resource] |
| 260 |
_bPloS one _c2018 |
||
| 300 |
_ae0204567 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCitrobacter rodentium _xpathogenicity |
| 650 | 0 | 4 |
_aColitis _xdrug therapy |
| 650 | 0 | 4 |
_aColon _ximmunology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aElectron Transport Complex I _xmetabolism |
| 650 | 0 | 4 |
_aElectron Transport Complex IV _xmetabolism |
| 650 | 0 | 4 |
_aEnterobacteriaceae Infections _xdrug therapy |
| 650 | 0 | 4 | _aHT29 Cells |
| 650 | 0 | 4 | _aHost Microbial Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
| 650 | 0 | 4 |
_aIntestinal Mucosa _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMitochondria _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xadministration & dosage |
| 700 | 1 | _aSharba, Sinan | |
| 700 | 1 | _aNavabi, Nazanin | |
| 700 | 1 | _aLindén, Sara K | |
| 773 | 0 |
_tPloS one _gvol. 13 _gno. 9 _gp. e0204567 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0204567 _zAvailable from publisher's website |
| 999 |
_c28872166 _d28872166 |
||